STAGE IIC PROSTATE CANCER AJCC V8
Clinical trials for STAGE IIC PROSTATE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIC PROSTATE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIC PROSTATE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart-Safe prostate cancer treatment? new study pits orgovyx against eligard
Disease control Recruiting nowThis study compares two hormone-lowering drugs, Orgovyx and Eligard, in men with prostate cancer who are also getting radiation. The goal is to see which drug causes fewer heart problems. About 70 men will take one of the drugs for 6 months and have their heart function tested be…
Matched conditions: STAGE IIC PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
New radiation approach may offer shorter, safer treatment for recurrent prostate cancer
Disease control Recruiting nowThis study tests whether a precise, short-course radiation therapy (SBRT) works as well as a slightly longer radiation approach (hypofractionated radiotherapy) for prostate cancer that has come back or spread to a few spots after surgery. About 118 men with low PSA levels will be…
Matched conditions: STAGE IIC PROSTATE CANCER AJCC V8
Phase: PHASE3 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:01 UTC
-
New hope for high-risk prostate cancer: targeted drug after radiation
Disease control Recruiting nowThis study is for men with high-risk prostate cancer that hasn't spread far. It tests whether adding the drug niraparib to standard hormone therapy after radiation can keep the cancer from coming back longer. About 200 participants will receive either hormone therapy alone or hor…
Matched conditions: STAGE IIC PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Hormone boost before scan may reveal hidden prostate cancer
Diagnosis Recruiting nowThis study tests whether taking a short course of hormone therapy (relugolix) before a PSMA PET/CT scan can make the scan better at finding prostate cancer that has spread. About 30 men with high-risk prostate cancer will get the hormone drug for 5, 10, or 15 days before their sc…
Matched conditions: STAGE IIC PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated May 13, 2026 16:03 UTC